It’sQA Associates Limited, an international clinical auditing and quality management company, is pleased to announce it will be attending BIOtech Japan 2017, 28th-30th June, in Tokyo.
BIOtech Japan is BioAsia's leading Bio and Pharma R&D event, specialising in Biotechnology, Drug Discovery, Pharmaceutical Development, Regenerative Medicine and Personalised Medicine.
This year, BIOtech Japan will be co-held with the newly launching show, BioPharma Expo 2017, covering Biopharma R&D and manufacturing. Other co-hosts include Interphex Japan, Japan's largest pharma manufacturing show, and In-Pharma Japan, a pharma ingredients show. This collaboration seeks to gather the entire Asian pharma industry under one roof, providing the ideal opportunity for delegates and exhibitors alike to expand their business in Japan and Asia.
Dr Piera Lukes, Managing Director, It’sQA, will be representing the company at this event. She commented “I am very excited about the prospect of building our company’s profile in Asia, of exploring new partnership opportunities, and gaining an insight into the latest innovations in this field.”
The conference this year is expected to include:
- 600 exhibitors
- 250 presentations across the conference and academic forum
- Excellent partnering opportunities via the Online Business Matching
In 2016 this event saw 504 exhibitors from 26 countries and regions, and gathered 6,057 attendees, illustrating the important position BIOtech Japan holds for international companies looking to expand and strengthen their business in Japan.
BIOtech Japan gathers not only Business Development Managers, but also academic and pharma researchers. It provides a unique opportunity in Asia to find a wide variety of potential business partners, ranging from end-users, Project Managers, Business Development Managers to CEOs.
For more information visit http://www.bio-t.jp/en/